Capricor Therapeutics
CAPR
#7318
Rank
S$0.73 B
Marketcap
S$12.59
Share price
9.44%
Change (1 day)
73.87%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): S-$1.59

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$3.13. In 2022 the company made an earnings per share (EPS) of S-$1.51 a decrease over its 2021 EPS that were of S-$1.11.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$1.595.61%
2022S-$1.5135.63%
2021S-$1.11-7.45%
2020S-$1.20-55.45%
2019S-$2.70-59.81%
2018S-$6.71-1850%
2017S$0.38-102.94%
2016S-$13.0425.93%
2015S-$10.3655.77%
2014S-$6.65-39.53%
2013S-$10.99-64.78%
2012S-$31.21-62.44%
2011S-$83.10-31.58%
2010S-$121.45-38.71%
2009S-$198.16-43.64%
2008S-$351.57-5.17%
2007S-$370.75427.27%
2006S-$70.31340.33%
2005S-$15.97
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.55-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$9.01-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S-$9.23 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.56 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S-$9.65 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$37.45 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA